Terms: = Leukemia AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Diagnosis
4 results:
1. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.
Chen X; Wen F; Li Z; Li W; Zhou M; Sun X; Zhao P; Zou C; Liu T
Cancer Med; 2022 Sep; 11(18):3479-3490. PubMed ID: 35488386
[TBL] [Abstract] [Full Text] [Related]
2. HDAC1 and klf4 interplay critically regulates human myeloid leukemia cell proliferation.
Huang Y; Chen J; Lu C; Han J; Wang G; Song C; Zhu S; Wang C; Li G; Kang J; Wang J
Cell Death Dis; 2014 Oct; 5(10):e1491. PubMed ID: 25341045
[TBL] [Abstract] [Full Text] [Related]
3. Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells.
Liu Y; Cheng H; Gao S; Lu X; He F; Hu L; Hou D; Zou Z; Li Y; Zhang H; Xu J; Kang L; Wang Q; Yuan W; Gao S; Cheng T
Leukemia; 2014 May; 28(5):1071-80. PubMed ID: 24150221
[TBL] [Abstract] [Full Text] [Related]
4. Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.
Amador-Ortiz C; Hurley MY; Ghahramani GK; Frisch S; Klco JM; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
J Cutan Pathol; 2011 Dec; 38(12):945-53. PubMed ID: 22050091
[TBL] [Abstract] [Full Text] [Related]
